¼¼°èÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå
Patient Monitoring Devices
»óǰÄÚµå : 1659319
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 92 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2030³â±îÁö 876¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 569¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 7.5%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 876¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ Ç÷´ç ¸ð´ÏÅ͸µ µð¹ÙÀ̽º´Â CAGR 7.8%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 232¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 8.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 147¾ï ´Þ·¯, Áß±¹Àº CAGR 11.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2024³â¿¡ 147¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 216¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 11.2%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 3.6%¿Í 6.6%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ȯÀÚ ¸ð´ÏÅ͸µ ±â±â°¡ Çö´ë ÀÇ·á¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ȯÀÚ ¸ð´ÏÅ͸µ ±â±â´Â Çö´ë ÀÇ·á¿¡ ¾ø¾î¼­´Â ¾È µÉ Çʼö ¿ä¼Ò·Î, ÁßÁõ ¹× ºñÁßÁõ ȯÀÚÀÇ È°·Â ¡ÈÄ¿Í »ý¸®Àû ¸Å°³ º¯¼ö¸¦ ½Ç½Ã°£À¸·Î ÃßÀûÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ½É¹Ú¼ö, È£Èí¼ö, Ç÷¾Ð, »ê¼ÒÆ÷È­µµ µîÀÇ ÁöÇ¥¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ¿© ÀÇ·áÁøÀÌ µ¥ÀÌÅÍ¿¡ ±â¹ÝÇÑ ÀÇ»ç°áÁ¤À» ³»¸®°í, °Ç°­ »óÅÂÀÇ º¯È­¿¡ ½Å¼ÓÇÏ°Ô ´ëÀÀÇÏ¿© ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÁßȯÀÚ½Ç, ¼ö¼ú ÈÄ È¸º¹±â, ¸¸¼ºÁúȯÀ» ¾Î°í Àִ ȯÀÚÀÇ °æ¿ì, Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» ÅëÇØ Á¤»ó ¹üÀ§¿¡¼­ ¹þ¾î³ª´Â °ÍÀ» Áï½Ã °¨ÁöÇÏ¿© »ý¸íÀ» ±¸ÇÒ ¼ö ÀÖ´Â Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á´Â Á¡Á¡ ´õ ¿¹¹æÀûÀÌ°í ¸ÂÃã Ä¡·á·Î ÀüȯµÇ°í ÀÖÀ¸¸ç, ȯÀÚ ¸ð´ÏÅ͸µ ±â±â´Â ȯÀÚÀÇ ¾ÈÀüÀ» À¯ÁöÇϰí Ä¡·áÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â µ¥ ÇʼöÀûÀÎ ÅøÀÔ´Ï´Ù.

¶ÇÇÑ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â´Â °£È£»ç ¹× ±âŸ °£º´ÀÎÀÇ ºó¹øÇÑ ¼öÀÛ¾÷ Á¡°ËÀÇ Çʿ伺À» ÁÙ¿© ÀÇ·á ½Ã¼³ÀÇ ¿öÅ©Ç÷οì È¿À²À» Çâ»ó½Ãŵ´Ï´Ù. ÀÚµ¿È­µÈ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» Á¦°øÇÔÀ¸·Î½á ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ´õ º¹ÀâÇÑ Ä¡·á ÀÛ¾÷°ú °³ÀÔ¿¡ ÁýÁßÇÒ ¼ö ÀÖ°í, °£º´ÀÎÀÇ ÇǷθ¦ ÁÙÀ̰í ÀÚ¿ø ¹èºÐÀ» ÃÖÀûÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM)Àº ÀÓ»óÀǰ¡ º´¿ø ¹Û¿¡¼­ ȯÀÚÀÇ °Ç°­ »óŸ¦ ÃßÀûÇÒ ¼ö ÀÖµµ·Ï ÇÔÀ¸·Î½á ÀÌ ±â´ÉÀ» ´õ¿í È®ÀåÇϰí, ±âÁ¸ÀÇ Áø·á ȯ°æÀ» ³Ñ¾î¼­¼­ Áø·á¸¦ È®ÀåÇϰí ÀÖÀ¸¸ç, RPMÀº ȯÀÚ°¡ Áý¿¡¼­ ÀÚ½ÅÀÇ °Ç°­ »óŸ¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á ÀæÀº º´¿ø ¹æ¹®À» ÁÙÀ̰í, ÀÇ·á ºñ¿ëÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ºñ¿ëÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖÀ¸¹Ç·Î ¸¸¼ºÁúȯ °ü¸®¿¡ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ¿¹¹æ°ú ÀçÅà ġ·á¸¦ Áß½ÃÇÏ´Â ÀÇ·á ¸ðµ¨ÀÌ ÁøÈ­ÇÔ¿¡ µû¶ó ȯÀÚ ¸ð´ÏÅ͸µ ±â±â´Â ȯÀÚÀÇ °Ç°­À» Áö¿øÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â´Â °Ç°­ ÇÕº´ÁõÀÇ Á¶±â ¹ß°ßÀ» °­È­ÇÏ°í ¸ÂÃã Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ´Â µ¥ ±â¿©ÇÕ´Ï´Ù. ¸ð´ÏÅ͸µ ±â±â¿¡¼­ Áö¼ÓÀûÀ¸·Î ¼öÁýµÇ´Â µ¥ÀÌÅ͸¦ ÅëÇØ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ÆÐÅÏÀ» ½Äº°Çϰí, °Ç°­ Ãß¼¼¸¦ ÃßÀûÇϰí, Çʿ信 µû¶ó Ä¡·á °èȹÀ» Á¶Á¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ½ÉÀå ¹× È£Èí±â ¸ð´ÏÅ͸µÀº ºÎÁ¤¸ÆÀ» Á¶±â¿¡ ¹ß°ßÇÏ¿© Àǻ簡 ¿¹¹æ Á¶Ä¡¸¦ ÃëÇÏ¿© ½É°¢ÇÑ ÇÕº´ÁõÀÇ °¡´É¼ºÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ½Å»ý¾Æ ¹× ¼Ò¾Æ ÀÇ·á¿¡¼­ »ê¼Ò ¹× ½É¹Ú¼ö ¸Å°³ º¯¼ö¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ´Â °ÍÀº Áõ»óÀ» Àü´ÞÇÒ ¼ö ¾ø´Â Ãë¾àÇÑ È¯ÀÚ¿¡°Ô Áß¿äÇÕ´Ï´Ù. ȯÀÚ ¸ð´ÏÅ͸µ ±â±â´Â »çÀü ¿¹¹æÀû °³º° Ä¡·á¸¦ Áö¿øÇÔÀ¸·Î½á ȯÀÚ °á°ú¸¦ °³¼±ÇÏ°í ¿¹¹æ °¡´ÉÇÑ ÇÕº´Áõ À§ÇèÀ» ÁÙÀÌ´Â µ¥ µµ¿òÀ» ÁÖ¸ç, ȯÀÚ Á᫐ ÀÇ·á¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù.

±â¼ú ¹ßÀüÀº ȯÀÚ ¸ð´ÏÅ͸µ ±â±â¸¦ ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº ȯÀÚ ¸ð´ÏÅ͸µ ±â±âÀÇ ±â´É, Á¤È®¼º, Á¢±Ù¼ºÀ» Å©°Ô Çâ»ó½ÃÄÑ ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡ º¸´Ù ´Ù¿ëµµÇϰí ÀûÇÕÇÏ°Ô ¸¸µé¾ú½À´Ï´Ù. ÁÖ¿ä ±â¼ú Çõ½Å Áß Çϳª´Â ¹«¼± ¿¬°á°ú »ç¹°ÀÎÅͳÝ(IoT)ÀÇ ÅëÇÕÀÔ´Ï´Ù. À̸¦ ÅëÇØ ¸ð´ÏÅ͸µ Àåºñ¿¡¼­ Áß¾Ó º´¿ø ½Ã½ºÅÛ, ½º¸¶Æ®Æù, Ŭ¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀ¸·Î ½Ç½Ã°£ µ¥ÀÌÅÍ Àü¼ÛÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. IoT ¿¬°áÀº ¿©·¯ ±â±âÀÇ µ¥ÀÌÅ͸¦ ÀÚµ¿À¸·Î ±â·ÏÇÏ¿© ÀÇ·áÁø°ú °øÀ¯ÇÔÀ¸·Î½á µ¥ÀÌÅÍÀÇ Á¤È®¼ºÀ» ³ôÀ̰í, ÀÓ»óÀǰ¡ Àû½Ã¿¡ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. Àû½Ã¿¡ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ°Ô µË´Ï´Ù. ¹«¼± ¹× IoT ÅëÇÕ ¸ð´ÏÅ͸µ Àåºñ´Â ¿øÈ°ÇÑ ¿¬°áÀ» ÅëÇØ È¿À²¼º°ú ȯÀÚ ÆíÀǼºÀ» Çâ»ó½ÃÄÑ Ãֽе¥ÀÌÅͺ£À̽º ÀÇ·á ¼­ºñ½º¸¦ Áö¿øÇÕ´Ï´Ù.

ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×Àº ¿¹Ãø ºÐ¼®, ÀÌ»ó ¡ÈÄ Á¶±â ¹ß°ß, °³ÀÎÈ­µÈ ÀλçÀÌÆ®À» Á¦°øÇÔÀ¸·Î½á ȯÀÚ ¸ð´ÏÅ͸µÀ» º¯È­½Ã۰í ÀÖÀ¸¸ç, AI ¾Ë°í¸®ÁòÀº ¸ð´ÏÅ͸µ ±â±â¿¡¼­ ¼öÁýµÈ ¹æ´ëÇÑ ¾çÀÇ È¯ÀÚ µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© ÀÓ¹ÚÇÑ °Ç°­ ¹®Á¦¸¦ ³ªÅ¸³¾ ¼ö ÀÖ´Â ¹Ì¹¦ÇÑ µ¿Çâ°ú ÀÌ»ó ¡Èĸ¦ ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹Ì¹¦ÇÑ Ãß¼¼¿Í ÀÏÅ»À» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ½ÉÀå ¸ð´ÏÅ͸µ¿¡¼­ AI´Â ºÎÁ¤¸ÆÀ» °¨ÁöÇÏ°í ½ÉÀ帶ºñ °¡´É¼ºÀ» ¿¹ÃøÇÒ ¼ö ÀÖÀ¸¸ç, ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ½É°¢ÇÑ »ç°ÇÀÌ ¹ß»ýÇϱâ Àü¿¡ ´ëóÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ¸Ó½Å·¯´× ¸ðµ¨Àº ¶ÇÇÑ °¢ ȯÀÚÀÇ °íÀ¯ÇÑ °Ç°­ ÆÐÅÏ¿¡ ÀûÀÀÇÏ¿© ¸ð´ÏÅ͸µÀ» °³ÀÎÈ­ÇÏ¿© ¿À°æº¸¸¦ ÃÖ¼ÒÈ­ÇÏ°í °¨Áö Á¤È®µµ¸¦ Çâ»ó½Ãŵ´Ï´Ù. AI¿Í ¸Ó½Å·¯´×Àº ¿¹ÃøÀû ÀλçÀÌÆ®À» Á¦°øÇÔÀ¸·Î½á ¸ð´ÏÅ͸µ ±â±âÀÇ ±â´ÉÀ» °­È­ÇÏ¿© »çÀü ¿¹¹æÀû Ä¡·á¸¦ Á¦°øÇϰí ÇÕº´ÁõÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù.

¿þ¾î·¯ºí ¸ð´ÏÅ͸µ ±â±â ¹× ÈÞ´ë¿ë ¸ð´ÏÅ͸µ ±â±â´Â ±âÁ¸ÀÇ º´¿ø ȯ°æ ¹Û¿¡¼­ °Ç°­ ÁöÇ¥¸¦ ½±°Ô ÃßÀûÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á ȯÀÚ ¸ð´ÏÅ͸µ¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ½º¸¶Æ®¿öÄ¡, Áö¼ÓÀû Ç÷´ç ÃøÁ¤±â, ÈÞ´ë¿ë ½ÉÀüµµ Àåºñ µîÀ» ÅëÇØ ȯÀÚµéÀº ÁýÀ̳ª À̵¿ Áß¿¡µµ ÀÚ½ÅÀÇ °Ç°­ »óŸ¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿þ¾î·¯ºí ±â±â¿¡´Â »ýü ½ÅÈ£¸¦ ÃøÁ¤ÇÏ´Â ¼¾¼­°¡ ÀåÂøµÇ¾î ÀÖÀ¸¸ç, ¸ð¹ÙÀÏ °Ç°­ ¾Û·Î ¿¬°áÇÏ¿© ȯÀÚ°¡ °Ç°­ Ãß¼¼¸¦ ÃßÀûÇϰí ÀÇ·áÁø°ú µ¥ÀÌÅ͸¦ °øÀ¯ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯ ȯÀڵ鿡°Ô ¿þ¾î·¯ºíÀº ÀæÀº º´¿ø ¹æ¹® ¾øÀ̵µ °Ç°­À» °ü¸®ÇÒ ¼ö ÀÖ´Â Æí¸®ÇÑ ¹æ¹ýÀ» Á¦°øÇÏ¿© ȯÀÚÀÇ ¼øÀÀµµ¿Í Âü¿©µµ¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ȯÀÚ ¸ð´ÏÅ͸µÀÌ ´õ¿í Ä£¼÷ÇØÁö°í, ¿¹¹æ ÀǷḦ Áö¿øÇϸç, ȯÀÚ°¡ ÀÚ½ÅÀÇ ÇコÄɾ Àû±ØÀûÀÎ ¿ªÇÒÀ» ÇÒ ¼ö ÀÖ°Ô µÉ °ÍÀÔ´Ï´Ù.

ȯÀÚ ¸ð´ÏÅ͸µ ±â±â´Â ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ¾î¶² ÀÌÁ¡ÀÌ Àִ°¡?

ȯÀÚ ¸ð´ÏÅ͸µ ±â±â´Â ȯÀÚ¿¡°Ô´Â °Ç°­ »óÅ °³¼±, ÆíÀǼº Çâ»ó, ÀÚ°¡ °ü¸® °­È­¿Í °°Àº Å« ÀÌÁ¡À» Á¦°øÇϸç, ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô´Â È¿À²ÀûÀÎ ÀÚ¿ø »ç¿ë, Àû½Ã¿¡ µ¥ÀÌÅÍ ÀλçÀÌÆ®, ´õ ³ªÀº ÀÓ»óÀû ÀÇ»ç°áÁ¤°ú °°Àº ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ȯÀÚÀÇ °æ¿ì, ¸ð´ÏÅ͸µ Àåºñ´Â Áö¼ÓÀûÀ¸·Î °³ÀÎÈ­µÈ °Ç°­ Æò°¡¸¦ Á¦°øÇϰí Á¤»ó ¼öÁØ¿¡¼­ ¹þ¾î³ª´Â °ÍÀ» Áï°¢ÀûÀ¸·Î °¨ÁöÇÒ ¼ö ÀÖµµ·Ï º¸ÀåÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ç½Ã°£ ¸ð´ÏÅ͸µÀº ´ç´¢º´, °íÇ÷¾Ð, ½ÉÀ庴°ú °°Àº ¸¸¼ºÁúȯÀ» ¾Î°í Àִ ȯÀڵ鿡°Ô ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. Æ÷µµ´ç ¸ð´ÏÅÍ, ÈÞ´ë¿ë ½ÉÀüµµ, Ç÷¾Ð°è¿Í °°Àº Àåºñ´Â ȯÀÚ°¡ Áý¿¡¼­ ÀÚ½ÅÀÇ »óŸ¦ ÃßÀûÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÖ¾î ÀæÀº º´¿ø ¹æ¹®ÀÇ Çʿ伺À» ÁÙÀÌ°í º¸´Ù µ¶¸³ÀûÀÎ »ýȰÀ» ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ÀÚ°¡ ¸ð´ÏÅ͸µÀÌ °¡´ÉÇØÁü¿¡ µû¶ó ÀÌ·¯ÇÑ ±â±âµéÀº ȯÀÚÀÇ ½Å·Úµµ, ¼øÀÀµµ ¹× Àü¹ÝÀûÀÎ ÇコÄɾ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ȯÀÚ ¸ð´ÏÅ͸µ ±â±â´Â Ȱ·Â ¡ÈÄ µ¥ÀÌÅÍ ¼öÁý ¹× Àü¼ÛÀ» ÀÚµ¿È­ÇÏ¿© ¿öÅ©Ç÷ο츦 °£¼ÒÈ­ÇÏ°í ¼öÀÛ¾÷ ÃøÁ¤ÀÇ Çʿ伺À» ÁÙ¿© ´Ù¸¥ ÀÓ»ó ¾÷¹«¿¡ ´õ ¸¹Àº ½Ã°£À» ÇÒ¾ÖÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. º´¿ø¿¡¼­ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ Àåºñ¸¦ ÅëÇØ °£È£»ç´Â ȯÀÚÀÇ ¹ÙÀÌÅ» »çÀθ¦ ÀÚÁÖ Ã¼Å©ÇÒ Çʿ䰡 ¾øÀ¸¹Ç·Î ȯÀÚ Á÷Á¢ °ü¸® ¹× º¸´Ù º¹ÀâÇÑ ¾÷¹«¿¡ ÁýÁßÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀº ÀÇ·á ÇÁ·Î¹ÙÀÌ´õ°¡ Áý¿¡¼­ ȯÀÚÀÇ °Ç°­ »óŸ¦ ÃßÀûÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á Á¶±â Åð¿øÀ» Áö¿øÇϰí, ÀçÀÔ¿øÀ²À» ³·Ã߸ç, º´»ó °¡µ¿·üÀ» ÃÖÀûÈ­ÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. ÀÇ·á ½Ã½ºÅÛ ÀÔÀå¿¡¼­´Â ÀÌ·¯ÇÑ È¿À²È­¸¦ ÅëÇØ ¿î¿µ ºñ¿ëÀ» Àý°¨Çϰí, ÀÇ·áÁøÀÌ °¡Àå Áß¿äÇÑ È¯ÀÚ¿¡°Ô ÁýÁßÇÒ ¼ö ÀÖÀ¸¸ç, ´õ ³ôÀº ¼öÁØÀÇ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

ȯÀÚ ¸ð´ÏÅ͸µ ±â±âÀÇ ¶Ç ´Ù¸¥ Å« ÀåÁ¡Àº µ¥ÀÌÅÍ ÀλçÀÌÆ®À» °­È­Çϰí ÀÇ»ç°áÁ¤À» °³¼±ÇÏ´Â °ÍÀÔ´Ï´Ù. Áö¼ÓÀûÀÎ ½Ç½Ã°£ µ¥ÀÌÅÍ ½ºÆ®¸²À» ¼öÁýÇÔÀ¸·Î½á ¸ð´ÏÅ͸µ Àåºñ´Â ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ȯÀÚÀÇ °Ç°­ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÏ¿© ¹®Á¦¸¦ Á¶±â¿¡ ¹ß°ßÇϰí ÇÕº´ÁõÀÌ ¹ß»ýÇϱâ Àü¿¡ °³ÀÔÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÁßȯÀڽǿ¡¼­´Â »ê¼ÒÆ÷È­µµ, ½É¹Ú¼ö, È£Èí¼ö µîÀÇ ÁöÇ¥¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ¿© ȯÀÚÀÇ »ý¸íÀ» À§ÇùÇÏ´Â »óÅ º¯È­¿¡ ½Å¼ÓÇÏ°Ô ´ëÀÀÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÓ»óÀÇ¿¡°Ô´Â Á¤È®ÇÏ°í ½Ã±âÀûÀýÇÑ µ¥ÀÌÅÍ¿¡ ´ëÇÑ Á¢±ÙÀ» ÅëÇØ ±Ù°Å¿¡ ±â¹ÝÇÑ ÆÇ´ÜÀ» ½±°Ô ³»¸± ¼ö ÀÖÀ¸¸ç, Áø´ÜÀÇ Á¤È®¼º°ú Ä¡·á È¿°ú¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±âÀÇ ÀåÁ¡Àº ³ôÀº ¼öÁØÀÇ ÀǷḦ Áö¿øÇϰí, ÀÇ·á ÇöÀå¿¡¼­ ȯÀÚ °á°ú¿Í ¾÷¹« È¿À²¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù.

ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ¼¼°è Àα¸ÀÇ °í·ÉÈ­, ¸ð´ÏÅ͸µ ±â¼úÀÇ ¹ßÀü, ¿ø°ÝÀÇ·á ¹× ¿ø°Ý Áø·áÀÇ È®´ë µîÀÇ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü Áúȯ, ´ç´¢º´, È£Èí±â Áúȯ°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¿¹¹æÀû Áúº´ °ü¸®¸¦ Áö¿øÇÏ´Â Áö¼ÓÀûÀÎ ÀçÅà ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀº Á¤±âÀûÀÎ ¸ð´ÏÅ͸µ°ú Àû½Ã¿¡ °³ÀÔÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ ȯÀÚ ¸ð´ÏÅ͸µ ±â±â´Â ȯÀÚ°¡ Áý¿¡¼­ ÀÚ½ÅÀÇ Áúº´À» °ü¸®ÇÒ ¼ö ÀÖ´Â ½Å·ÚÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ¸¸¼ºÁúȯÀÇ È®»ê¿¡ µû¶ó ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀº Ä¡·á °á°ú¸¦ °³¼±Çϰí ÀÔ¿øÀÇ Çʿ伺À» ÁÙÀ̱â À§ÇØ ÀÌ·¯ÇÑ ±â±â¸¦ µµÀÔÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

°í·ÉÈ­µµ ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â Áß¿äÇÑ ¿äÀÎÀÔ´Ï´Ù. °í·ÉÀÚ´Â ³ëÈ­ °ü·Ã Áúȯ ¹× ¸¸¼ºÁúȯÀÇ À§ÇèÀÌ ³ô±â ¶§¹®¿¡ Áö¼ÓÀûÀÎ °Ç°­ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. ¸ð´ÏÅ͸µ ±â±â¸¦ ÅëÇØ ³ëÀΠȯÀÚµéÀº ÀÚ½ÅÀÇ °Ç°­ »óÅ¿¡ ´ëÇÑ Á¤º¸¸¦ Áö¼ÓÀûÀ¸·Î Á¦°ø¹ÞÀ» ¼ö ÀÖ°í, Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖÀ¸¸ç, ÀÀ±Þ »óȲ ¹ß»ý °¡´É¼ºÀ» ³·Ãß°í, ÀÚ¸³À» µµ¿ï ¼ö ÀÖ½À´Ï´Ù. Àü ¼¼°è¿¡¼­ ³ëÀÎ Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ³ëÀÎÀÇ »îÀÇ Áú À¯Áö¸¦ µ½´Â Á¢±Ù¼º°ú »ç¿ë ÆíÀǼºÀ» °®Ãá ¸ð´ÏÅ͸µ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ȯÀÚ ¸ð´ÏÅ͸µ ±â±â´Â °í·ÉÈ­ »çȸÀÇ ¿ä±¸¿¡ ºÎÀÀÇÏ°í °Ç°­ÇÑ ³ëÈ­¸¦ ÃËÁøÇÏ´Â ÀçÅà °£È£ ¹× º¹Áö ½Ã¼³¿¡¼­ÀÇ »ýȰ¿¡ ÇʼöÀûÀÎ ÅøÀÌ µÇ°í ÀÖ½À´Ï´Ù.

AI, IoT, ¿þ¾î·¯ºí ±â±âÀÇ ÅëÇÕÀ» Æ÷ÇÔÇÑ ¸ð´ÏÅ͸µ ±â¼úÀÇ ¹ßÀüÀº ȯÀÚ ¸ð´ÏÅ͸µ ±â±âÀÇ ±â´É°ú Á¢±Ù¼ºÀ» È®´ëÇÏ¿© ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖÀ¸¸ç, IoT Áö¿ø ¸ð´ÏÅ͸µ ±â±â´Â ¿©·¯ Ç÷§Æû¿¡¼­ ½Ç½Ã°£ µ¥ÀÌÅÍ °øÀ¯¸¦ °¡´ÉÇÏ°Ô Çϰí, AI´Â ¿¹Ãø ºÐ¼®°ú °³ÀÎÈ­µÈ ÀλçÀÌÆ®À» Á¦°øÇÏ¿© ȯÀÚ Ä¡·á¸¦ °­È­ÇÕ´Ï´Ù. AI´Â ¿¹Ãø ºÐ¼®°ú °³ÀÎÈ­µÈ ÀλçÀÌÆ®À» Á¦°øÇÏ¿© ȯÀÚ Ä¡·á¸¦ °­È­ÇÕ´Ï´Ù. ¿þ¾î·¯ºí ±â±â´Â ÀÏ»ó »ýȰ¿¡ ¸ð´ÏÅ͸µÀ» µµÀÔÇÏ¿© ȯÀÚ°¡ Áö¼ÓÀûÀ¸·Î °Ç°­ ÁöÇ¥¸¦ ÃßÀûÇϰí ÇコÄɾ º¸´Ù Àû±ØÀûÀ¸·Î Âü¿©ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀ¸·Î ¸ð´ÏÅ͸µ ±â±â´Â ´õ¿í ÀûÀÀ·ÂÀÌ ¶Ù¾î³ª°í Á¢±Ù¼ºÀÌ ³ô¾ÆÁ³À¸¸ç, ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ¿¡°Ô ¸Å·ÂÀûÀ¸·Î ´Ù°¡¿Í º´¿ø, ¿Ü·¡ Áø·á ¹× ÀçÅà Áø·á ȯ°æ¿¡¼­ÀÇ º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¿ø°ÝÀÇ·á ¹× ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM) ¼­ºñ½ºÀÇ È®´ë´Â ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼­ºñ½º¿¡´Â ȯÀÚÀÇ Áý¿¡¼­ °Ç°­ µ¥ÀÌÅ͸¦ ¼öÁýÇϰí ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô Àü¼ÛÇÒ ¼ö ÀÖ´Â Àåºñ°¡ ÇÊ¿äÇϱ⠶§¹®ÀÔ´Ï´Ù. ¿ø°ÝÀÇ·á´Â ƯÈ÷ COVID-19 ÆÒµ¥¹Í »óȲ¿¡¼­ ȯÀÚ°¡ Á÷Á¢ ¹æ¹®ÇÏÁö ¾Ê°íµµ Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖÀ¸¹Ç·Î Á¡Á¡ ´õ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ¿ø°Ý Ç÷¾Ð°è, ½ÉÀüµµ°è, Ç÷´ç ÃøÁ¤±â¿Í °°Àº RPM ±â±â´Â ½Ç½Ã°£ °Ç°­ ÃßÀû ¹× Àû½Ã °³ÀÔÀ» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ÀÌ·¯ÇÑ Ä¡·á ¸ðµ¨À» ÃËÁøÇÕ´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ ¿ø°ÝÀǷḦ ÀÏ»ó Áø·á¿¡ °è¼Ó ÅëÇÕÇÔ¿¡ µû¶ó °¡»ó Áø·á¸¦ Áö¿øÇϴ ȯÀÚ ¸ð´ÏÅ͸µ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ½ÃÀå È®ÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸¸¼ºÁúȯÀÇ È®»ê, °í·ÉÈ­, ±â¼ú ¹ßÀü, ¿ø°ÝÀÇ·áÀÇ È®´ë µî ¿©·¯ ¿äÀÎÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ¿¹¹æ, °³ÀÎÈ­, Á¢±Ù¼º ³ôÀº Ä¡·á¸¦ ¿ì¼±½ÃÇÏ´Â °¡¿îµ¥, ȯÀÚ ¸ð´ÏÅ͸µ ±â±â´Â Çö´ë ÀÇ·á Àü·«ÀÇ Áß½ÉÀÌ µÇ°í ÀÖÀ¸¸ç, ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ ´õ ³ªÀº Ä¡·á °á°ú¿Í ȯÀÚ Âü¿© °­È­¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

¸ð´ÏÅ͸µ Àåºñ(Ç÷´ç, ½ÉÀå, ´ÙÁß ¸Å°³º¯¼ö, È£Èí±â, ü¿Â, Ç÷ÇൿÅÂ/Ç÷¾Ð, žÆ/½Å»ý¾Æ, ±âŸ ¸ð´ÏÅ͸µ Àåºñ) ;& ÃÖÁ¾»ç¿ëó(º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ, ÀçÅÃÀÇ·á ȯ°æ, ±âŸ ÃÖÁ¾»ç¿ëó)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÇÕ°è 36 ÁÖ¸ñ)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Patient Monitoring Devices Market to Reach US$87.6 Billion by 2030

The global market for Patient Monitoring Devices estimated at US$56.9 Billion in the year 2024, is expected to reach US$87.6 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Blood Glucose Monitoring Device, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$23.2 Billion by the end of the analysis period. Growth in the Cardiac Monitoring Device segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$14.7 Billion While China is Forecast to Grow at 11.2% CAGR

The Patient Monitoring Devices market in the U.S. is estimated at US$14.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$21.6 Billion by the year 2030 trailing a CAGR of 11.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Patient Monitoring Devices Market - Key Trends & Drivers Summarized

Why Are Patient Monitoring Devices Essential in Modern Healthcare?

Patient monitoring devices have become indispensable in modern healthcare, enabling real-time tracking of vital signs and physiological parameters for patients in critical and non-critical care. These devices continuously monitor metrics like heart rate, respiratory rate, blood pressure, and oxygen saturation, allowing healthcare providers to make data-driven decisions, respond quickly to health changes, and improve patient outcomes. For patients in intensive care units, post-operative recovery, and those with chronic diseases, continuous monitoring ensures that any deviation from normal ranges is detected immediately, allowing timely interventions that can be life-saving. With healthcare increasingly shifting toward preventive and personalized care, patient monitoring devices are essential tools in maintaining patient safety and improving quality of care.

Patient monitoring devices also facilitate more efficient workflows within healthcare facilities, as they reduce the need for frequent manual checks by nurses and other caregivers. By providing automated, continuous monitoring, these devices enable healthcare providers to focus on more complex care tasks and interventions, reducing caregiver fatigue and optimizing resource allocation. Remote patient monitoring (RPM) has further expanded this capability by allowing clinicians to track patients’ health from outside the hospital, extending care beyond traditional settings. RPM is especially beneficial for chronic disease management, as it enables patients to monitor their health at home, reduces the need for frequent hospital visits, and minimizes healthcare costs. As healthcare models evolve to emphasize preventive and home-based care, patient monitoring devices play a crucial role in supporting patient well-being.

Moreover, patient monitoring devices contribute to better patient outcomes by enhancing early detection of health complications and enabling personalized treatment. With data continuously collected from monitoring devices, healthcare providers can identify patterns, track health trends, and make adjustments to treatment plans as needed. In cardiac and respiratory monitoring, for example, early identification of irregularities allows physicians to take preventive measures, reducing the likelihood of severe complications. In neonatal and pediatric care, continuous monitoring of oxygen and heart rate parameters is critical for vulnerable patients who cannot communicate symptoms. By supporting proactive, individualized care, patient monitoring devices help improve patient outcomes and reduce the risk of preventable complications, making them essential in patient-centered healthcare.

How Are Technological Advancements Enhancing Patient Monitoring Devices?

Technological advancements are significantly enhancing the functionality, accuracy, and accessibility of patient monitoring devices, making them more versatile and suitable for a range of healthcare settings. One major innovation is the integration of wireless connectivity and the Internet of Things (IoT), which enables real-time data transmission from monitoring devices to central hospital systems, smartphones, and cloud-based platforms. Wireless devices reduce patient restrictions and allow them to move freely, improving comfort and quality of life while being continuously monitored. IoT connectivity ensures that data from multiple devices is automatically recorded and shared with healthcare providers, enhancing data accuracy and allowing clinicians to make timely, informed decisions. By enabling seamless connectivity, wireless and IoT-integrated monitoring devices improve efficiency and patient comfort, supporting modern, data-driven healthcare.

Artificial Intelligence (AI) and machine learning are transforming patient monitoring by enabling predictive analytics, early anomaly detection, and personalized insights. AI algorithms can analyze vast amounts of patient data collected from monitoring devices, identifying subtle trends or deviations that may indicate an impending health issue. For example, in cardiac monitoring, AI can detect arrhythmias and predict the likelihood of a heart attack, allowing healthcare providers to act before a critical event occurs. Machine learning models also personalize monitoring by adapting to each patient's unique health patterns, minimizing false alarms and improving detection accuracy. By providing predictive insights, AI and machine learning enhance the capability of monitoring devices to deliver proactive care and reduce complications.

Wearable and portable monitoring devices are also revolutionizing patient monitoring by making it easier to track health metrics outside of traditional hospital settings. Devices like smartwatches, continuous glucose monitors, and portable ECGs allow patients to monitor their health in real-time, whether at home or on the go. These wearables are equipped with sensors that measure vital signs and connect to mobile health apps, allowing patients to track their health trends and share data with their healthcare providers. For chronic disease patients, wearables provide a convenient way to manage health without frequent hospital visits, enhancing patient compliance and engagement. As wearable technology advances, it is making patient monitoring more accessible, supporting preventive care and empowering patients to take an active role in managing their health.

What Are the Benefits of Patient Monitoring Devices for Patients and Healthcare Providers?

Patient monitoring devices offer significant benefits for patients by improving health outcomes, enhancing comfort, and empowering self-management, while healthcare providers benefit from efficient resource use, timely data insights, and better clinical decision-making. For patients, monitoring devices provide a continuous, personalized assessment of their health, ensuring that any deviations from normal levels are detected immediately. This real-time monitoring is particularly beneficial for individuals with chronic conditions like diabetes, hypertension, or cardiac disorders, as it enables them to monitor and manage their health actively. Devices such as glucose monitors, portable ECGs, and blood pressure cuffs help patients track their conditions at home, reducing the need for frequent doctor visits and allowing them to lead more independent lives. By enabling self-monitoring, these devices improve patient confidence, compliance, and overall health management.

For healthcare providers, patient monitoring devices streamline workflows by automating the collection and transmission of vital sign data, reducing the need for manual measurements and freeing up time for other clinical tasks. Continuous monitoring devices in hospitals eliminate the need for nurses to frequently check patients' vitals, allowing them to focus on direct patient care and more complex tasks. Additionally, remote patient monitoring solutions support early discharge by enabling providers to continue tracking patients' health from home, reducing hospital readmission rates and optimizing bed availability. For healthcare systems, these efficiencies reduce operational costs and support a higher standard of care, as providers can focus their efforts on patients who require the most attention.

Enhanced data insights and improved decision-making are other significant benefits of patient monitoring devices. By collecting a continuous stream of real-time data, monitoring devices provide healthcare providers with a comprehensive view of a patient’s health trends, allowing them to detect issues early and intervene before complications arise. In critical care settings, continuous monitoring of metrics like oxygen saturation, heart rate, and respiratory rate enables rapid responses to life-threatening changes in patient conditions. For clinicians, access to accurate and timely data facilitates evidence-based decisions, improving diagnostic accuracy and treatment efficacy. Together, these benefits of patient monitoring devices support a high standard of care, enhancing patient outcomes and operational effectiveness across healthcare settings.

What Is Fueling the Growth in the Patient Monitoring Devices Market?

The growth in the patient monitoring devices market is driven by factors such as the rising prevalence of chronic diseases, an aging global population, advancements in monitoring technology, and the expansion of telehealth and remote care. The increasing prevalence of chronic diseases, such as cardiovascular disease, diabetes, and respiratory disorders, has created a demand for continuous and home-based monitoring solutions that support proactive disease management. With chronic diseases often requiring regular monitoring and timely intervention, patient monitoring devices provide a reliable way for patients to manage their conditions from home. As chronic conditions become more widespread, healthcare providers are adopting these devices to improve care outcomes and reduce the need for hospitalization, driving growth in the market.

The aging population is another significant driver of growth in the patient monitoring devices market. Older adults often require continuous health monitoring due to age-related conditions and a higher risk of chronic diseases. Monitoring devices enable elderly patients to stay informed about their health and receive timely interventions, reducing the likelihood of emergencies and supporting independence. As the global population of older adults grows, there is increasing demand for accessible, easy-to-use monitoring devices that help them maintain their quality of life. Patient monitoring devices are becoming essential tools for home care and assisted living environments, meeting the needs of aging populations and promoting healthier aging.

Advancements in monitoring technology, including the integration of AI, IoT, and wearable devices, are also fueling growth by expanding the functionality and accessibility of patient monitoring devices. IoT-enabled monitoring devices allow for real-time data sharing across multiple platforms, while AI provides predictive analytics and personalized insights, enhancing patient care. Wearable devices have brought monitoring into everyday life, allowing patients to track health metrics continuously and engage more actively in their health management. These technological advancements make monitoring devices more adaptable, accessible, and appealing to both patients and healthcare providers, driving adoption in hospitals, outpatient care, and at-home settings.

The expansion of telehealth and remote patient monitoring (RPM) services has further propelled growth in the patient monitoring devices market, as these services require devices that can collect and transmit health data from patients’ homes to healthcare providers. Telehealth has become increasingly popular, particularly during the COVID-19 pandemic, as it allows patients to receive care without the need for in-person visits. RPM devices such as remote blood pressure monitors, ECGs, and glucose meters facilitate this model of care by enabling real-time health tracking and timely intervention. As healthcare systems continue to integrate telehealth into routine care, the demand for patient monitoring devices that support virtual care is expected to increase, driving market expansion.

Together, these factors—rising chronic disease prevalence, an aging population, advancements in technology, and the expansion of telehealth—are driving significant growth in the patient monitoring devices market. As healthcare providers prioritize preventive, personalized, and accessible care, patient monitoring devices are becoming central to modern healthcare strategies, supporting better outcomes and enhanced patient engagement across diverse care settings.

SCOPE OF STUDY:

The report analyzes the Patient Monitoring Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Monitoring Device (Blood Glucose, Cardiac, Multi-Parameter, Respiratory, Temperature, Hemodynamic / Pressure, Fetal & Neonatal, Other Monitoring Devices); End-Use (Hospitals, Ambulatory Surgery Centers, Home Care Settings, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â